BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wickramasinghe N, Devanarayana NM. Insight into global burden of gastroesophageal reflux disease: Understanding its reach and impact. World J Gastrointest Pharmacol Ther 2025; 16(1): 97918 [PMID: 40094147 DOI: 10.4292/wjgpt.v16.i1.97918]
URL: https://www.wjgnet.com/2307-8960/full/v16/i1/97918.htm
Number Citing Articles
1
I. G. Bakulin, N. V. Bakulina, Yu. G. Topalova, S. V. Tikhonov, N. V. Pavlova. “GeFest” questionnaire: New diagnostic options for GERD and functional dyspepsiaMeditsinskiy sovet = Medical Council 2025; (15): 28 doi: 10.21518/ms2025-430
2
Tingting Xu, Fuxing Wen, Jiayuan Zhao, Wei Zhang. Endoscopic Anti-Reflux Mucosal Interventions for Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis of Efficacy, Safety, and Comparative OutcomesDigestive Diseases 2025; : 1 doi: 10.1159/000548198
3
Hideki Mizuno, Shingo Inagaki, Kazutoshi Yamada, Shinji Kamiyamamoto. Follow-up study of vonoprazan maintenance therapy for reflux esophagitis: A 96-week evaluation in patients with PPI-refractory diseaseBiomedical Reports 2025; 23(4): 1 doi: 10.3892/br.2025.2038